David H. White
Mallinckrodt
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David H. White.
Inorganica Chimica Acta | 1987
Dennis W. Wester; David H. White; Fred W. Miller; Richard T. Dean; John A. Schreifels; Jerry E. Hunt
Abstract Technetium(I) complexes of trimethylphosphite (tmp), dimethylmethylphosphonite (dmmp) and methyldiethylphosphinite (mdep) have been synthesized through direct interaction of the ligand with sodium pertechnetate. The homoeleptic, hexakis (ligand), cationic complexes can be isolated as tetraphenylborate salts. Characterization using multinuclear NMR of 99 Tc (−422 and −248 ppm versus TcO 4 − for the tmp and dmmp complexes, respectively) and 31 P (158.5 and 248 ppm versus 85% H 3 PO 4 for the tmp and dmmp complexes, respectively) gives chemical shift values which compare favorably with previous data on Tc-phosphine and transition-metal-phosphite complexes. Mass spectra (fast atom bombardment and plasma desorption) of the tmp and dmmp complexes exhibit the expected parent peaks and show series of peaks attributed to stepwise loss of ligand molecules or possible decompositon products. X-ray photoelectron spectra of the tmp and dmmp complexes are consistent with formulation as the Tc(I) oxidation state when referenced to well-characterized complexes in known oxidation states.
Magnetic Resonance Imaging | 1994
Mark E. Bosworth; Thomas J. Dunn; Warren Earl Hall; Richard Gardner Johnson; Mills T. Kneller; Youlin Lin; Rebecca A. Wallace; David H. White; David M. Wong
The use of reverse osmosis as an alternative or substitute method for the purification of a crude diagnostic agent. X-ray contrast agent, magnetic resonance imaging agent, or radiopharmaceuticals are purified by passing through a cross-linked reverse osmosis membrane.
Magnetic Resonance Imaging | 1995
David H. White; Steven R. Woulfe; Youlin Lin; Mills T. Kneller
Methods and compositions are disclosed for enhancing 19 F magnetic resonance imaging which utilize trifluoromethyl derivatives of iodinated X-ray contrast media. Typical magnetic resonance contrast media within the scope of the present invention include bis(trifluoromethyl)benzene derivatives, tris(trifluoromethyl)benzene derivatives, tetrakis(trifluoromethyl)benzene derivatives, and other related trifluoromethylated benzene derivatives.
Archive | 1985
Richard T. Dean; Youlin Lin; Robert W. Weber; David H. White
Archive | 1992
Dennis A. Moore; Max D. Adams; William P. Cacheris; David H. White; Muthunadar P. Periasamy; Raghavan Rajagopalan; Lynn deLearie; Steven R. Woulfe
Archive | 1992
Edward Deutsch; Karen F. Deutsch; William P. Cacheris; William H. Ralston; David H. White; Dennis L. Nosco; Robert G. Wolfangel; Janet B. Wilking; Linda Meeh; Steven R. Woulfe
Archive | 1992
Edward A. Deutsch; Karen F. Deutsch; William P. Cacheris; William P. Ralston; David H. White; Steven R. Woulfe
Magnetic Resonance Imaging | 1995
Edward Deutsch; Karen F. Deutsch; Dennis L. Nosco; William H. Ralston; David H. White; Janet B. Wilking; Robert G. Wolfangel; Steven R. Woulfe
Archive | 1991
Narciso O. Doran; Thomas J. Dunn; Mills T. Kneller; Youlin Lin; David H. White; David M. Wong
Inorganic Chemistry | 1984
Dennis W. Wester; David H. White; Fred W. Miller; Richard T. Dean